Health And Medicine

Eighteen departments and agencies of the federal government have joined to propose revised regulations for scientific research involving human subjects. Read More

A team of Vanderbilt University Medical Center scientists are closer to understanding why COX-2 inhibitors — drugs that relieve arthritis pain and inflammation without the gastrointestinal side effects of other painkillers — cause heart problems in some patients. Now Read More

Despite benefiting from dramatic improvements in movement after deep brain stimulation surgery, patients with Parkinson’s disease can be inadequately served when physicians and researchers focus only on its motor manifestations, says a Vanderbilt neurosurgeon. Read More

New Department of Radiation Oncology Chair Lisa Kachnic wants to make Vanderbilt's program one of the best in the country. Read More

A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines. Read More

A “bundle” of electronically implemented care guidelines reduced intensive care unit patient complications related to mechanical ventilation. Read More

Vanderbilt researchers could be one step closer to finding a way to fight the deadly Ebola virus – thanks to two Ebola victims from Nigeria, who faced death and survived. Vanderbilt researchers developed a unique method of isolating potent Ebola-fighting antibodies from survivors’ blood and they believe these newest… Read More

Drugs that inhibit the Wnt signaling pathway can regenerate injured skin and may be useful in treating fibromatosis, degenerative joint disease and cancer. Read More

The irregular heart rhythm atrial fibrillation increases the risk of death in patients in the intensive care unit. Read More

Bethany Rhoten’s research focuses on issues that few people openly discuss—those surrounding body image and sexuality among cancer survivors. Read More

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year $660,633 grant from the National Institute of Health’s National Institute on Aging to study how psychophysical responses to acute experimental thermal pain differ between older adults with and without Alzheimer’s Disease (AD). Read More

Another non-opioid option besides nerve blocks works better for patients recovering from knee replacement surgery, according to a study by Andrew Shinar, M.D., associate professor of Orthopaedic Surgery and Rehabilitation. Read More

Nine months after arriving as the new associate director of the Vanderbilt Transplant Center and eight days after the pediatric liver transplant program at Monroe Carell Jr. Children’s Hospital at Vanderbilt was launched, surgeon Douglas Hanto transplanted a new liver into 10-year-old Aubree Vanzant. Read More

Deonni Stolldorf’s research focuses on determining how innovations in health care can be sustained to enhance organizational performance related to patient safety and the quality and effectiveness of care. Read More

Vanderbilt University has been awarded a major federal grant — $16 million over four years — to coordinate AIDS education and training efforts in Tennessee and seven other southeastern states. Read More

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases. Read More

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read More

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation. Read More

Lymphedema patients saw a nearly 80 percent reduction in cellulitis episodes by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology co-authored by Vanderbilt University School of Nursing’s Sheila Ridner, Ph.D., and University of Minnesota School of Public Health Associate Professor Pinar Karaca-Mandic, Ph.D. Read More

Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections. Read More